{"title":"【PET扫描如何用于帕金森病?】","authors":"J Tedroff","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>PET (positron emission tomography) has yielded manifest improvements in our knowledge of Parkinson's disease, in terms of pathological and pharmacological aspects. Since PET was introduced in study of Parkinson's disease 15 years ago, the technique has been steady refined, and more tracers are becoming available. The possibility of monitoring the dopamine system in longitudinal studies will no doubt become cornerstone in the evaluation of neuroprotective therapies.</p>","PeriodicalId":19261,"journal":{"name":"Nordisk medicin","volume":"113 2","pages":"48, 52"},"PeriodicalIF":0.0000,"publicationDate":"1998-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[How can PET scan be used in Parkinson disease?].\",\"authors\":\"J Tedroff\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>PET (positron emission tomography) has yielded manifest improvements in our knowledge of Parkinson's disease, in terms of pathological and pharmacological aspects. Since PET was introduced in study of Parkinson's disease 15 years ago, the technique has been steady refined, and more tracers are becoming available. The possibility of monitoring the dopamine system in longitudinal studies will no doubt become cornerstone in the evaluation of neuroprotective therapies.</p>\",\"PeriodicalId\":19261,\"journal\":{\"name\":\"Nordisk medicin\",\"volume\":\"113 2\",\"pages\":\"48, 52\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nordisk medicin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nordisk medicin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PET (positron emission tomography) has yielded manifest improvements in our knowledge of Parkinson's disease, in terms of pathological and pharmacological aspects. Since PET was introduced in study of Parkinson's disease 15 years ago, the technique has been steady refined, and more tracers are becoming available. The possibility of monitoring the dopamine system in longitudinal studies will no doubt become cornerstone in the evaluation of neuroprotective therapies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
